Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid) A Receptor
The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
Certain classes of neuroactive steroids (NASs) are positive allosteric modulators (PAM) of synaptic and extrasynaptic GABA A receptors. Herein, we report new SAR insights in a series of 5β-nor-19-pregnan-20-one analogues bearing substituted pyrazoles and triazoles at C-21, culminating in the discovery of 3α-hydroxy-3β-methyl-21-(4-cyano-1 H -pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217, 3 ), a potent GABA A receptor modulator at both synaptic and extrasynaptic receptor subtypes, with excellent oral DMPK properties. Compound 3 has completed a phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial and is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD), major depressive disorder (MDD), and essential tremor (ET).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NAS GABAAR PAMs have pharmacological profiles and binding sites distinct from benzodiazepines,40,41 with the ability to modulate the activity of both synaptic and extrasynaptic GABAARs.39,42”
From Effect of Zuranolone vs Placebo in Postpartum Depression (2021) · cites this paper as [42]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752
Neurosteroids and GABAA receptor function
Lambert, J. J., Belelli, D., Hill-Venning, C., & Peters, J. A. (1995) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)89058-6 · Cited by 746
GABAergic dysfunction in mood disorders
Brambilla, P., Perez, J., Barale, F., Schettini, G., & Soares, J. C. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001362 · Cited by 553
GABA-based therapeutic approaches: GABAA receptor subtype functions
RUDOLPH, U., & MOHLER, H. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.10.003 · Cited by 499
Extrasynaptic GABA A Receptors: Form, Pharmacology, and Function
Belelli, D., Harrison, N. L., Maguire, J., Macdonald, R. L., Walker, M. C., & Cope, D. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3340-09.2009 · Cited by 464
A single histidine in GABAA receptors is essential for benzodiazepine agonist binding.
Wieland, H. A., Lüddens, H., & Seeburg, P. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45961-3 · Cited by 447
Impact of solid state properties on developability assessment of drug candidates
Huang, L. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.007 · Cited by 438
Subunit-Specific Trafficking of GABAAReceptors during Status Epilepticus
Goodkin, H. P., Joshi, S., Mtchedlishvili, Z., Brar, J., & Kapur, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3426-07.2008 · Cited by 322
Research works printed but not linked: 1
- 10.1016/j.eplepsyres.2015.01.001 · DOI · Paper page
Cited by
Items 101–136 of 136
TO MARKET, TO MARKET—2023: SMALL MOLECULES
Araujo, E., Bartels, B., Bell, I. M., Castanedo, G. M., Zeng, M., Dhar, T. G. M., Holmberg‐Douglas, N., Welin, E. R., Koester, D. C., León, B., et al. (2024) · Medicinal chemistry reviews · doi:10.1021/mc-2024-vol59.ch19 · Cited by 3
Modern approaches to the pharmacotherapy of postpartum depression
Овчинников, А. В., & Иродионовна, В. Т. (2020) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2020-11-70-81 · Cited by 4
New Therapeutic Modalities: Transforming Drug Discovery and Development
Blanco, M.-J. (2024) · Springer eBooks · doi:10.1007/978-3-031-35529-5_135 · Cited by 3
Self-citationYang, Y., Deng, X., Xu, H., Chen, D., Zhao, F., Yang, H., Wang, W., Sha, C., Ma, M., Zhang, G., et al. (2025) · Molecules · doi:10.3390/molecules30091918 · Cited by 2
“…literature has reported the use of methylaluminum bis(2,6-di-Scheme Previous literature has reported the use of methylaluminum bis(2,6-di-tert-butyl-4-methylphenoxide) (MAD) in combination with Grignard reagents to control both the chemical and stereoselective introduction of methyl groups [16].”
Edilova, Y. O., Kudyakova, Y. S., Osipova, E. A., Slepukhin, P. A., Burgart, Y. V., Салоутин, В. И., & Бажин, Д. Н. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110335 · Cited by 2
Recent advances in GABAA receptor targeting ligands
Zuo, Y., Zhao, Y., Liu, G., & Sun, Q. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118651 · Cited by 2
Deng, Y., Wang, S., Geng, L., Meng, Z., Chen, F., Yang, X., Wang, F., Chen, Y., Li, Z., & Xie, Z. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00858 · Cited by 2
Neuroactive Steroids in Hypoxic–Ischemic Brain Injury: Overview and Future Directions
Toro-Urrego, N., Ávila-Rodriguez, M., Herrera, M. I., Aguilar, A., Udovin, L., & Luaces, J. P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93956 · Cited by 2
Rodriguez, M. A., Felsztyna, I., García, D. A., Sánchez-Borzone, M. E., & Miguel, V. (2024) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2024.124891 · Cited by 2
Tian, M., Wu, J., Fan, L., Zhou, J., Wang, X., Hu, J., Yu, H., & Xu, B. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01161 · Cited by 2
Novel Neurosteroid Pharmaceuticals
Susser, L. C., Swanson, C., & Hermann, A. D. (2021) · Advances in Psychiatry and Behavioral Health · doi:10.1016/j.ypsc.2021.05.017 · Cited by 2
Zuranolone in postpartum depression: a profile of its use in the USA
Blair, H. A. (2024) · Drugs & Therapy Perspectives · doi:10.1007/s40267-024-01074-9 · Cited by 1
Assessing the utility of the neurosteroid zuranolone to modify alcohol-related behaviours
Ursich, L. T., Pearl, A. J., Maddern, X. J., Lawrence, A. J., & Walker, L. C. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110833 · Cited by 1
Mareš, P., Chodounská, H., Szczurowska, E., Kubova, H., & Kudová, E. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s566239 · Cited by 1
Structure-property Relationships Reported for the New Drugs Approved in 2023
Choi, K. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575308674240415074629 · Cited by 1
Treatment-resistant depression in pregnancy, the postpartum period, and transition to menopause
Kaufman, Y., Eichenbaum, R. M., Carlini, S. V., & Deligiannidis, K. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00037-2 · Cited by 1
The Search for Rapid Acting Antidepressants: Research Synthesis and Perspectives
Sanacora, G., Kitay, B. M., & Wilkinson, S. T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813333-0.00035-4
Comment on “Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids”
Rubinow, D. R., Lasser, R. A., & Kanes, S. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20121681
Sage 217 (Zuranolone) for Treatment of Major Depressive Disorder
Beresis, R. T. (2022) · Wiley eBooks · doi:10.1002/9781119847281.ch14
Self-citationZhang, M., Wang, W., Guo, C., & Jiang, C. (2023) · Journal of Chemical Research · doi:10.1177/17475198231204213
Breaking new ground: Cutting-edge GABAA receptor modulators for epilepsy treatment
Blanco, M.-J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00050-9
Self-citationNovas abordagens á Depressão Pós- Parto: Moduladores Alostéricos Positivos do Recetor GABA-A
Oliveira, F. S. (2024) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/mexy-zr26
Duncan, E., Hersant, H., & Khairova, R. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-15772-0_4
Wang, H., Liao, W., Li, Y., Guo, A., Liu, Z., Guo, X., Wang, K., Zheng, Y., Wang, Z., Wang, W., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03830
Regio- and Stereoselective Synthesis and Stereochemical Assignment of Ganaxolone C-3/C-5 AnaloguesPreprint
Juřica, J., Chodounská, H., Pazderková, M., Králík, F., Buděšínský, M., Bednářová, L., & Kudová, E. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7525273
Kato, M., Baba, T., Sonoyama, T., & Iwata, N. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1891881
BindingDB Entry 50021320: Synthesis and clinical application of new drugs approved by FDA in 2023.
BindingDB (2025) · UC San Diego · doi:10.7270/q2zw1rjx
BindingDB Entry 50019131: Breakthroughs in neuroactive steroid drug discovery.
BindingDB (2024) · UC San Diego · doi:10.7270/q2mp57kh
BindingDB Entry 50018239: Synthetic Approaches to the New Drugs Approved during 2019.
BindingDB (2024) · UC San Diego · doi:10.7270/q29p35t8
BindingDB Entry 50012286: New drug approvals for 2019: Synthesis and clinical applications.
BindingDB (2022) · UC San Diego · doi:10.7270/q2hd80bx
Metadata
- Authors
- Martinez Botella, G., Salituro, F. G., Harrison, B. L., Beresis, R. T., Bai, Z., Blanco, M.-J., Belfort, G. M., Dai, J., Loya, C. M., Ackley, M. A., Althaus, A. L., Grossman, S. J., Hoffmann, E., Doherty, J. J., & Robichaud, A. J.
- Affiliations
- Sage Therapeutics, Inc. 215 First Street, Cambridge, Massachusetts 02142, United States
- Sage Therapeutics (United States) (US)
- Shanghai Chempartner, 998 Halei Road, Shanghai 201203, China
- WuXi AppTec (China) (CN)
- Corresponding author
- Salituro, Francesco G.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-08-17
- Volume
- 60
- Issue
- 18
- Pages
- 7810-7819
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2740680044
- Cited by
- 129
- References
- 26
- Citations by year
- 2026: 11 · 2025: 11 · 2024: 24 · 2023: 21 · 2022: 9 · 2021: 16 · 2020: 16 · 2019: 12 · 2018: 8 · 2017: 1
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- neurosteroids, GABAA receptor, positive allosteric modulators, structure-activity relationship, extrasynaptic GABAA receptors, oral bioavailability, pharmacokinetics, postpartum depression, major depressive disorder, essential tremor
- MeSH terms
- Allosteric Regulation, Animals, Depressive Disorder, Major, Major Depressive Disorder, Female, Pregnanolone, Pyrazoles, Receptors, GABA-A, Depression, Postpartum, Mice, Rats, GABA-A Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.